The association between the serum uric acid to creatinine ratio and all-cause mortality in elderly hemodialysis patients.
All-cause mortality
Elderly
Hemodialysis
SUA/Scr
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
06 05 2022
06 05 2022
Historique:
received:
14
01
2022
accepted:
21
04
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
Elderly hemodialysis patients have a higher rate of mortality than nonelderly hemodialysis patients. Recent studies shown that the serum uric acid to creatinine ratio (SUA/Scr) was associated with all-cause mortality in general adults. The purpose of the present study was to investigate the association between the SUA/Scr and all-cause and cardiovascular disease mortality among elderly hemodialysis patients. A total of 222 patients (≥ 60 years) who received hemodialysis more than 8 h per week at Taizhou Second People's Hospital for at least 3 months were enrolled in the present study from January 2015 to December 2019. Clinical characteristics including age, sex and height et. al, were obtained from the hemodialysis database. The laboratory data, including albumin (ALB), total cholesterol (TC), serum uric acid (SUA), serum creatinine (Scr) and so on, were collected before hemodialysis and analyzed by automatic biochemical analyzer. Survival information was recorded during the follow-up period. Multiple Cox regression was carried out to analyze the association between SUA/Scr and all-cause mortality. The survival rate of each group was calculated by the Kaplan-Meier method, and the ratio of survival curves was analyzed by the log-rank test. The contribution of SUA/Scr for predicting all-cause mortality risk was evaluated by net reclassification improvement (NRI). During the 19-month observation period, 78 patients died. Individuals in the nonsurviving group had significantly older ages (P < 0.001), body mass index (BMI) (P = 0.004), serum creatinine (P = 0.005) and prealbumin (P = 0.006) than surviving patients. After adjusting for age, sex, BMI, prealbumin, dialysis vintage, dialysis frequency, single-pool Kt/V (spKt/V), DM, hypertension and comorbidities, a higher ratio of SUA/Scr was independently associated with a higher risk of all-cause mortality (HR: 1.292; 95% CI: 1.013-1.648; P = 0.039). The predict value on all-cause mortality of SUA/Scr was superior to SUA (additive NRI = 0.214, P = 0.015) and Scr (additive NRI = 0.476, P < 0.001) among elderly hemodialysis patients. The serum uric acid to creatinine ratio is strongly associated with all-cause mortality in elderly hemodialysis patients which is more predictive than SUA or Scr alone.
Sections du résumé
BACKGROUND
Elderly hemodialysis patients have a higher rate of mortality than nonelderly hemodialysis patients. Recent studies shown that the serum uric acid to creatinine ratio (SUA/Scr) was associated with all-cause mortality in general adults. The purpose of the present study was to investigate the association between the SUA/Scr and all-cause and cardiovascular disease mortality among elderly hemodialysis patients.
METHODS
A total of 222 patients (≥ 60 years) who received hemodialysis more than 8 h per week at Taizhou Second People's Hospital for at least 3 months were enrolled in the present study from January 2015 to December 2019. Clinical characteristics including age, sex and height et. al, were obtained from the hemodialysis database. The laboratory data, including albumin (ALB), total cholesterol (TC), serum uric acid (SUA), serum creatinine (Scr) and so on, were collected before hemodialysis and analyzed by automatic biochemical analyzer. Survival information was recorded during the follow-up period. Multiple Cox regression was carried out to analyze the association between SUA/Scr and all-cause mortality. The survival rate of each group was calculated by the Kaplan-Meier method, and the ratio of survival curves was analyzed by the log-rank test. The contribution of SUA/Scr for predicting all-cause mortality risk was evaluated by net reclassification improvement (NRI).
RESULTS
During the 19-month observation period, 78 patients died. Individuals in the nonsurviving group had significantly older ages (P < 0.001), body mass index (BMI) (P = 0.004), serum creatinine (P = 0.005) and prealbumin (P = 0.006) than surviving patients. After adjusting for age, sex, BMI, prealbumin, dialysis vintage, dialysis frequency, single-pool Kt/V (spKt/V), DM, hypertension and comorbidities, a higher ratio of SUA/Scr was independently associated with a higher risk of all-cause mortality (HR: 1.292; 95% CI: 1.013-1.648; P = 0.039). The predict value on all-cause mortality of SUA/Scr was superior to SUA (additive NRI = 0.214, P = 0.015) and Scr (additive NRI = 0.476, P < 0.001) among elderly hemodialysis patients.
CONCLUSION
The serum uric acid to creatinine ratio is strongly associated with all-cause mortality in elderly hemodialysis patients which is more predictive than SUA or Scr alone.
Identifiants
pubmed: 35524224
doi: 10.1186/s12882-022-02798-4
pii: 10.1186/s12882-022-02798-4
pmc: PMC9077848
doi:
Substances chimiques
Prealbumin
0
Uric Acid
268B43MJ25
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
177Informations de copyright
© 2022. The Author(s).
Références
Nephrol Dial Transplant. 2004 Feb;19(2):457-62
pubmed: 14736974
Metab Syndr Relat Disord. 2021 Mar;19(2):70-75
pubmed: 33314991
Metab Syndr Relat Disord. 2019 Sep;17(7):380-387
pubmed: 31237480
PLoS One. 2014 Mar 26;9(3):e93286
pubmed: 24671212
Hypertension. 2000 Dec;36(6):1072-8
pubmed: 11116127
Kidney Res Clin Pract. 2019 Jun 30;38(2):169-175
pubmed: 31189222
Int J Cardiol. 2021 Mar 1;326:189-193
pubmed: 32535029
Front Endocrinol (Lausanne). 2020 Nov 19;11:600472
pubmed: 33329401
Clin J Am Soc Nephrol. 2011 Oct;6(10):2470-7
pubmed: 21868616
Am J Nephrol. 2020;51(10):823-832
pubmed: 33070128
Diabetes Metab Res Rev. 2018 Jul;34(5):e3001
pubmed: 29504280
J Am Soc Nephrol. 1993 Nov;4(5):1205-13
pubmed: 8305648
Am J Kidney Dis. 2011 Sep;58(3):418-28
pubmed: 21601335
Int Urol Nephrol. 2013 Aug;45(4):1111-9
pubmed: 22828740
Nutrition. 2015 Jan;31(1):138-47
pubmed: 25466658
Am J Kidney Dis. 2014 Aug;64(2):257-64
pubmed: 24176223
Diab Vasc Dis Res. 2017 May;14(3):221-225
pubmed: 28183204
Sci Rep. 2017 Sep 21;7(1):12104
pubmed: 28935934
Lung. 2007 Jan-Feb;185(1):21-4
pubmed: 17294336
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
pubmed: 17569110
J Ren Nutr. 2015 Nov;25(6):488-93
pubmed: 26139338
Metab Syndr Relat Disord. 2019 Mar;17(2):81-89
pubmed: 30614758
Am J Kidney Dis. 2020 Jan;75(1 Suppl 1):A6-A7
pubmed: 31704083
Medicine (Baltimore). 2020 Apr;99(17):e19959
pubmed: 32332681
J Clin Med Res. 2020 Mar;12(3):172-179
pubmed: 32231753
Clin J Am Soc Nephrol. 2011 Jul;6(7):1651-62
pubmed: 21734085
Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1015-23
pubmed: 27026520
Nephrol Dial Transplant. 2013 Aug;28(8):2146-55
pubmed: 23743018
Ther Adv Chronic Dis. 2020 Sep 29;11:2040622320949060
pubmed: 33062235
Ren Fail. 2020 Nov;42(1):646-655
pubmed: 32662307
Am J Kidney Dis. 2015 Nov;66(5):884-930
pubmed: 26498416
Arthritis Rheumatol. 2018 Jul;70(7):1122-1132
pubmed: 29694719
Kidney Int Rep. 2020 Jun 02;5(8):1196-1206
pubmed: 32775819
J Clin Epidemiol. 1988;41(3):237-42
pubmed: 3339376
Blood Purif. 2018;45(4):320-326
pubmed: 29402775
Kidney Int. 2005 Nov;68(5):2323-30
pubmed: 16221236
J Diabetes Complications. 2019 Jul;33(7):473-476
pubmed: 31047777